Drawing for SYMBIANT

USPTO serial 79092663

SYMBIANT

Reviewed by CopyMark Law Group

Reg. 4097633Status 404
Filing date
Status date
Registration date
Feb 14, 2012
Examiner
GUTTADAURO, JULIE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SYMBIANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
016Printed matter, photographs, instructional and teaching material (except apparatus) for the presentation of anatomical and pathological properties and of the chemical, biochemical, physical and physiological processes as part of the evaluation of the safety of drugs (medicines)SECTION 71 - CANCELLED—
042Scientific research for medical purposes; analysis and evaluation of the results of pathological and toxicological research for the purpose of, inter alia, the safety aspects of drugs (medicines), as well advice on the results thereof; services of a laboratory; laboratory research, including in the field of microbiology and infectious diseases; medical laboratory research; technical consultancy about the design of interior of laboratories and technical consultancy about the use and application of laboratory equipment; diagnostic tests, identification of the side-effects and carcinogenic properties of drugs (medicines); evaluation of clinical tests; research with regard to the safety and side-effects of drugs (medicines), as well as the carcinogenic properties of drugs (medicines); research relating to risk analyses of risk analyses of drugs (medicines)SECTION 71 - CANCELLED—
044Medical services; medical research; medical and diagnostic services related to the safety aspects of drugs (medicines); medical consultancy; services of pathologists; consultancy with regard to the safety and side-effects of drugs (medicines), as well as the carcinogenic properties of drugs (medicines)SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 1, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 9, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 17, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 17, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
May 21, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 21, 2018C71TCANCELLED SECTION 71—
May 15, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 6, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 21, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 22, 2012FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 14, 2012GPNXNOTIFICATION PROCESSED BY IB—
Jun 28, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 28, 2012FIMPFINAL DISPOSITION PROCESSED—
May 14, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 14, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 29, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 23, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 9, 2011NPUBNOTICE OF PUBLICATION—
Oct 27, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 26, 2011ALIEASSIGNED TO LIE—
Sep 29, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 2011RFNTREFUSAL PROCESSED BY IB—
Mar 3, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 3, 2011RFRRREFUSAL PROCESSED BY MPU—
Mar 3, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 2, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 18, 2011DOCKASSIGNED TO EXAMINER—
Feb 18, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 17, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance